title: Postoperative irradiation in localized renal cell carcinoma: the Rambam Medical Center experience.
abstract: OBJECTIVE
  This study evaluated the results of postoperative adjuvant radiotherapy in patients with localized renal cell carcinoma (RCC).
  
  
  METHODS
  Eighty-six patients (median age, 60 years) with RCC treated by radical nephrectomy were evaluated for the efficacy of postoperative radiotherapy. Twenty-four percent of patients had stage T2, 35% T3a, 36% T3b and 5% T4 disease. Seventy-seven percent had clear cell carcinomas and 23% granular cell or spindle and mixed cell carcinomas. Radiotherapy was given to the renal bed and adjacent lymphatic basin at a median dose of 46 Gy.
  
  
  RESULTS
  Thirty-two (37%) patients relapsed: 27 (84%) had systemic relapse only and five (16%) had local and systemic relapse; all patients of the latter group had stage T3b disease. The 10-year disease-free and overall survival was 40% and 42%, respectively. Tumor invasion of the renal vessels and stage of disease were correlated with survival. Side effects of radiotherapy were mainly gastrointestinal, but one patient who received right abdominal irradiation died because of liver failure.
  
  
  CONCLUSIONS
  The results of our study are comparable with those reported in the literature. Since postoperative irradiation did not improve the survival of patients with RCC and showed toxicity, it is not recommended.
authors.affiliation: Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. e_gez@rambam.health.gov.il
authors.forename: Eliahu
authors.initials: E
authors.lastname: Gez
authors.forename: Michael
authors.initials: M
authors.lastname: Libes
authors.forename: Raquel
authors.initials: R
authors.lastname: Bar-Deroma
authors.forename: Rafael
authors.initials: R
authors.lastname: Rubinov
authors.forename: Moshe
authors.initials: M
authors.lastname: Stein
authors.forename: Abraham
authors.initials: A
authors.lastname: Kuten
mesh_terms: D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000532:radiotherapy* / Q000556:secondary / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007557:Israel; D007680:Kidney Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009392:Nephrectomy; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis; D016896:Treatment Outcome